SCHEMBL17632015

SCHEMBL17632015

Cc1noc(C)c1-c1cnc2nc(N(C#N)C(=O)[C@H]3CCNC3)sc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.38
▸ BRD4 O60885 15/20 0.38
▸ CCNT1 O60563 1/20 0.34
▸ CCNK O75909 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK7 P50613 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CCNH P51946 1/20 0.34
▸ CDK12 Q9NYV4 1/20 0.34
▸ BRD2 P25440 3/20 0.34
▸ BRD3 Q15059 2/20 0.34
▸ CREBBP Q92793 2/20 0.33
▸ UCHL1 P09936 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17632567 0.87 BRD4 (0.47) USP30BRD4BRD2BRD3CREBBP
SCHEMBL17632023 0.85 USP30 (0.42) USP30BRD4BRD2BRD3CREBBP
SCHEMBL17632188 0.83 CYP1A2 (0.38) USP30BRD4USP2ALDH1A1LMNA
SCHEMBL17632216 0.78 BRD4 (0.41) USP30BRD4BRD2BRD3CREBBP
SCHEMBL17631968 0.77 USP30 (0.36) USP30BRD4BRD2BRD3CREBBP
SCHEMBL17631794 0.76 USP30 (0.35) USP30BRD4BRD2BRD3USP2
SCHEMBL17631887 0.75 USP30 (0.44) USP30BRD4UCHL1
SCHEMBL17632035 0.74 ABL1 (0.45) —
SCHEMBL17631916 0.73 USP30 (0.38) USP30BRD4BRD2BRD3CREBBP
SCHEMBL17631727 0.72 MAPT (0.44) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback